Relating to the establishment of a consortium to conduct United States Food and Drug Administration's drug development clinical trials with ibogaine to secure the administration's approval of the medication's use for treatment of opioid use disorder, co-occurring substance use disorder, and any other neurological or mental health conditions for which ibogaine demonstrates efficacy and to the administration of that treatment.
Relating to the route designation for the issuance of a permit for the movement of oversize and overweight vehicles that serve a deepwater seaport on the U.S.-Mexico Border.
Relating to prohibited retaliation against a physician or health care provider for reporting certain violations or taking certain actions with respect to the provision of health care services; providing a civil remedy.
Relating to conducting an assessment of language accessibility with respect to certain health and human services programs and 2-1-1 services provided by the Texas Information and Referral Network.